Alpha Teknova, Inc. (TKNO) Financials

TKNO Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 98.7 million 33.7 million
Dec. 31, 2025 103.6 million 34.8 million
Sept. 30, 2025 107.6 million 35.0 million
June 30, 2025 110.5 million 34.4 million

TKNO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -3.6 million 695000
Dec. 31, 2025 -710000 777000
Sept. 30, 2025 -2.3 million 850000
June 30, 2025 -2.3 million 950000

TKNO Net Income

No data available :(

TKNO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 4.3 million 12.7 million -
Dec. 31, 2025 5.9 million 13.3 million 15.1 million
Sept. 30, 2025 3.2 million 14.0 million 15.9 million
June 30, 2025 24.0 million 13.0 million 15.9 million

TKNO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 53.6 million
Dec. 31, 2025 53.5 million
Sept. 30, 2025 53.5 million
June 30, 2025 53.4 million

TKNO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 221000 609000 7.2 million 2.1 million
Dec. 31, 2025 348000 522000 7.0 million 1.8 million
Sept. 30, 2025 387000 542000 6.4 million 1.7 million
June 30, 2025 207000 581000 6.5 million 1.6 million

TKNO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 11.1 million 7.6 million
Dec. 31, 2025 10.0 million 6.7 million
Sept. 30, 2025 10.5 million 7.2 million
June 30, 2025 10.3 million 6.3 million

TKNO Revenue by Segment
Graph available only for paid members. Upgrade to see it.

TKNO

Price: $4.85

52 week price:
1.91
7.48

Earnings Per Share: -0.31 USD

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 32300

Market Capitalization: 213.9 million

Links: